Fig. 3From: A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trialNo statistically significant changes were observed in the FENO measurements during the trial. Data are displayed as mean ± SEM. Pre: Pre-Treatment; Post: Post-Treatment; FU: Follow-upBack to article page